MCKENZIE DECKER: Open Payments
NPI 1245801141 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 11 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $142 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $67 |
| Amgen Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Dexcom, Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $22 |
| Viatris Specialty LLC | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Boston Scientific Corporation | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: RECORLEV, OTEZLA, Dexcom G6 Transmitter, Cologuard Collection Kit, YUPELRI, UBRELVY, Ozempic, General - Pain Management.
Industry payments across ID — which companies pay providers there.
